PBYI - Puma Biotechnology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
299.42M
Enterprise Value 3
316.61M
Trailing P/E
N/A
Forward P/E 1
-5.06
PEG Ratio (5 yr expected) 1
-0.02
Price/Sales (ttm)
1.07
Price/Book (mrq)
17.43
Enterprise Value/Revenue 3
1.13
Enterprise Value/EBITDA 6
-7.79

Trading Information

Stock Price History

Beta (3Y Monthly) 1.65
52-Week Change 3-67.34%
S&P500 52-Week Change 319.27%
52 Week High 343.90
52 Week Low 36.26
50-Day Moving Average 38.11
200-Day Moving Average 310.46

Share Statistics

Avg Vol (3 month) 31.72M
Avg Vol (10 day) 32.76M
Shares Outstanding 538.96M
Float 30.13M
% Held by Insiders 113.44%
% Held by Institutions 1100.94%
Shares Short (Nov 15, 2019) 46.62M
Short Ratio (Nov 15, 2019) 44.08
Short % of Float (Nov 15, 2019) 419.28%
Short % of Shares Outstanding (Nov 15, 2019) 417.00%
Shares Short (prior month Oct 15, 2019) 48.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -33.91%
Operating Margin (ttm)-17.45%

Management Effectiveness

Return on Assets (ttm)-13.22%
Return on Equity (ttm)-301.43%

Income Statement

Revenue (ttm)280.42M
Revenue Per Share (ttm)7.27
Quarterly Revenue Growth (yoy)-10.00%
Gross Profit (ttm)216.37M
EBITDA -40.65M
Net Income Avi to Common (ttm)-95.09M
Diluted EPS (ttm)-2.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)110.44M
Total Cash Per Share (mrq)2.84
Total Debt (mrq)120.04M
Total Debt/Equity (mrq)698.70
Current Ratio (mrq)1.71
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)27.86M
Levered Free Cash Flow (ttm)65.93M